Related Experiment Video
Updated: Jun 3, 2026
04:11
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Quantification of HCV RNA in Liver Tissue by bDNA Assay
P J Dailey1, M L Collins, M S Urdea
1Nucleic Acid Diagnostics and New Markers, Chiron Diagnostics, Emeryville, CA.
Methods in Molecular Medicine
|March 5, 2011
Summary
Quantifying analytes in tissue, like Hepatitis C Virus RNA in liver biopsies, faces challenges in distribution, reference standards, and reproducible recovery. The bDNA assay offers a method to overcome these for accurate Hepatitis C Virus RNA measurement.
Area of Science:
- Biochemistry
- Virology
- Medical Diagnostics
Background:
- Quantitative measurement of analytes in tissue samples presents significant challenges.
- These include analyte distribution, establishing a reference standard (denominator), and ensuring reproducible analyte recovery during extraction.
- Hepatitis C Virus (HCV) RNA measurement in liver biopsies is subject to these complexities.
Purpose of the Study:
- To describe a method for the quantitative measurement of Hepatitis C Virus (HCV) RNA in liver biopsy and tissue samples.
- To address the challenges of analyte distribution, denominator standardization, and quantitative recovery in HCV RNA analysis.
Main Methods:
- Utilized the branched DNA (bDNA) assay for quantitative analysis.
- Applied the method to liver biopsy and tissue samples for Hepatitis C Virus (HCV) RNA detection.
Main Results:
- The described method allows for quantitative measurement of Hepatitis C Virus (HCV) RNA.
- The bDNA assay addresses the key challenges of distribution, denominator, and recovery in tissue sample analysis.
Conclusions:
- Accurate quantitative measurement of Hepatitis C Virus (HCV) RNA in liver biopsies is achievable.
- The bDNA assay provides a viable solution for overcoming critical analytical challenges in tissue-based viral RNA quantification.
